Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alliant To Detail Allegra Oral Suspension

This article was originally published in The Pink Sheet Daily

Executive Summary

The two-year contract covers U.S. pediatricians and pediatric sub-specialties.

You may also be interested in...



Child’s Play: Sciele To Boost Pediatric Presence With Alliant Acquisition

Deal worth $122 million gives Sciele products including Orapred and oral suspension of Allegra.

Child’s Play: Sciele To Boost Pediatric Presence With Alliant Acquisition

Deal worth $122 million gives Sciele products including Orapred and oral suspension of Allegra.

InVentiv Will Redeploy Sanofi-Aventis Reps To Santarus By Year End

Recent acquisitions and contract shifts have broadened the contract sales organization’s revenue base, minimizing loss of Allegra contract, inVentiv CEO Broshy says.

Related Content

Topics

UsernamePublicRestriction

Register

PS063514

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel